WHO ICTRP trial
Effect of amantadine on methamphetamine-withdrawal induced fatigue
IRCT2015111524853N2 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT2015111524853N2 |
|---|---|
| Public title | Effect of amantadine on methamphetamine-withdrawal induced fatigue |
| Scientific title | Effect of amantadine on controlling methamphetamine-withdrawal induced fatigue (double-blind, controlled clinical trial) |
| Primary sponsor | Deputy of research and technology developement, Ahvaz Jundishapur University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | Fatigue. Malaise and fatigue;Malaise and fatigue |
| Interventions | Intervention 1: Amantadine given to the active drug group 100 mg Capsule one capsule per day for 1 month. Intervention 2: palacebo given to placebo group placebo capsule, one per day for 1 month.;Treatment - Drugs;Placebo;Amantadine given… |
| Registration date | May 26, 2016 |
| Target size | 36 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: